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Abstract
Background: There are controversial evidences on the effect of different types and workloads of
physical exercise on primary hemostasis. In particular, little is known on the chronic influence of a
strenuous and regular aerobic training regimen on platelet function.
Methods: The aim of this investigation was to compare platelet function between sedentary
controls and trained athletes at rest and to evaluate whether a greater amount of exercise
performed in professional cyclists may contribute to increased platelet chronic responsiveness
compared to both elite cyclists and sedentary individuals. Platelet's ability to adhere and aggregate
was assayed following a 12–24 h resting period in 49 active professional male road cyclists, 40 elite
male cyclists and 43 matched sedentary healthy male volunteers, by the platelet function analyzer
100 (PFA-100).
Results and discussion: Mean values of the collagen-epinephrine test did not differ between
controls and athletes (sedentary controls: 111 ± 33 s; elite athletes: 113 ± 26 s, p = 0.93;
professional athletes: 120 ± 33 s; p = 0.33), whereas mean values of the collagen-ADP test displayed
a slightly but significant trend towards decreased values when comparing sedentary controls (83 ±
21 s) with either elite (77 ± 11 s, p < 0.01) or professional (75 ± 16 s, p < 0.01) athletes.
Conclusion: The trend towards slightly lower collagen-ADP values are suggestive for a modest
but significant chronic activation of primary hemostasis, highlighting the need to set appropriate
reference ranges for the PFA-100 when evaluating primary hemostasis in physically active subjects.
Background
Recent guidelines recommend 30 minutes or more of
daily, moderate-intensity physical exercise on the basis of
favorable biological adaptations and substantial health
benefits, which include a reduced risk of developing car-
diovascular disorders, cancer and other chronic patholo-
gies [1]. Although it appears to exist a linear relation
between physical activity and global health status, such
that a further increase in physical activity and fitness will
lead to additional improvements in health status [2],
there is debate regarding intensity and type of physical
activity required to achieve beneficial health changes
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without overwhelming favorable outcomes and eliciting
cardiovascular abnormalities not present at rest [1,3]. In
particular, there are still controversial evidences on the
relation between physical exercise and primary hemosta-
sis [3-10]. Therefore, the aim of this investigation was to
compare platelet function between sedentary controls and
trained athletes at rest and to evaluate whether a greater
amount of exercise performed in professional cyclists may
contribute to influence the chronic platelet responsive-
ness compared to both elite cyclists and sedentary individ-
uals.
Methods
Platelet's ability to adhere and aggregate was monitored
with the use of the platelet function analyzer 100 (PFA-
100, Dade International Inc. Miami, FL, USA) PFA-100 in
49 active professional male road cyclists, 40 elite male
cyclists and 43 sedentary healthy male volunteers,
matched for ethnic origin (all Caucasian), age (sedentary
controls: 29 ± 9 y, elite cyclists: 28 ± 12 y, p = 0.501; pro-
fessional cyclists: 28 ± 4 y, p = 0.311) and smoking habit
(all non-smokers). Unlike platelet aggregation studies, the
PFA-100 is a test relatively easy and rapid to perform,
which provides a rapid evaluation of primary hemostasis
and platelet function on whole blood anticoagulated
specimens. The analyzer uses a disposable cartridge which
internal active membrane is coated with either collagen-
ADP (CADP) or collagen-epinephrine (CEPI). The inter-
action of whole anticoagulated blood with the agonists, in
condition of high shear rates, triggers platelet activation
and the resulting formation of a stable platelet plug inter-
rupts the blood flow, which is recorded in term of closure
time (CT) [11]. Athletes reached our Center in the middle
of the competitive season, during a regular, high-work-
load period of aerobic training. All subjects recruited to
the study were in a fasted state and athletes had rested for
a period of 12–24 h since the last training session or com-
petition. The consumption of drugs known to interfere
with platelet function, along with clinically symptomatic
platelet disorders, were carefully excluded by clinical his-
tory and physical examination in both the athlete and
control populations. The research was carried out accord-
ing to the principles of the Declaration of Helsinki; the
study protocol was reviewed and approved by the ethics
committee of our Department, and informed consent for
testing was received from all individuals included in this
study. Blood was collected in the morning from fasting
subjects by venipuncture with 20 gauge (G) straight nee-
dles (Terumo Europe NV, Leuven, Belgium), directly into
siliconized vacuum tubes containing 0.105 mol/l buff-
ered trisodium citrate (Becton-Dickinson, Oxford, UK).
Samples for PFA-100 testing were immediately analyzed,
whereas specimens for coagulation studies were centri-
fuged at 1500 g for 10 min at 15°C, plasma was separated,
stored in aliquots and kept frozen at -70°C until measure-
ment. Von Willebrand factor (VWF) was measured on the
Mini Vidas Immunoanalyzer (bioMerieux, Marcy l'Etoile,
France), by a rapid and quantitative enzyme-linked
immunosorbent assay. Significance of differences
between samples was assessed by Student's t-test; the level
of statistical significance was set at p < 0.05.
Results and discussion
The average intensity of daily physical exercise was sub-
stantially different among the three study populations
(sedentary controls <10 min/day, elite cyclists 30–90
min/day and pro cyclists >90 min/day). When comparing
results of the PFA-100 between sedentary individuals
(CADP: 83 ± 21 s; CEPI: 111 ± 33 s) and athletes, mean
values of CEPI appeared substantially unvaried by the
physical activity (elite athletes: 113 ± 26 s; p = 0.93 and
professional athletes: 120 ± 33 s; p = 0.33), whereas mean
CADP values displayed a slightly but significant trend
towards decreased values in either elite (77 ± 11 s; p <
0.01) or professional (75 ± 16 s; p < 0.01) athletes (Figure
1). In athletes, and particularly in professionals, the distri-
bution is more homogeneous for CAPD values than CEPI
ones, regardless of a similar number of outliers for both
CEPI and CAPD, which are correspondent to the same
athletes. Results of VWF measurement did not differ sig-
nificantly between controls (106 ± 14 IU/dl) and either
elite (107 ± 13 IU/dl, p = 0.258) or professional cyclists
(108 ± 14 IU/dl, p = 0.144).
Growing evidences indicate that benefit of physical activ-
ity on cardiovascular disease may result to some extent
from effects on hemostasis [10-13]. Accordingly, for reha-
bilitation training it is recommended that the intensity of
exercise should be distinctly below the individual anaero-
bic threshold. It is hence debated whether a strenuous aer-
obic exercise might counterbalance these advantageous
modifications [1-3] and no definitive data are still availa-
ble on the influence of physical exercise on primary
hemostasis. Although it has been reported that acute bout
of moderate-intensity exercise may reduce platelet activa-
tion [4], earlier studies observed acute platelet activation,
aggregation and adhesion during physical exercise, as
evaluated by ADP and collagen-induced aggregation [5],
platelet granularity [6], filtragometry [7], enhanced
release of soluble P-selectin and intracellular Ca2+ [8],
downregulation of glycoprotein Ib [9] and moderate
increase of platelet-leukocyte conjugates [10].
However, no data are available so far for the PFA-100 ana-
lyzer on blood samples collected from professional ath-
letes at rest, undergoing a strenuous and regular aerobic
training regimen. Although this is only a preliminary
observation and even though the values of the PFA-100
observed in competitive athletes are still within normal
ranges [14], the modestly decreased CADP values provideThrombosis Journal 2006, 4:10 http://www.thrombosisjournal.com/content/4/1/10
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Value distribution of collagen-ADP (CADP) or collagen-epinephrine (CEPI) induced aggregation on the PFA-100 system in sed- entary healthy controls, elite and professional road cyclists Figure 1
Value distribution of collagen-ADP (CADP) or collagen-epinephrine (CEPI) induced aggregation on the PFA-100 system in sed-
entary healthy controls, elite and professional road cyclists. The central horizontal line indicates the mean value.
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evidence of a slight, persistent platelet activation in elite
and professional athletes, providing further insight to the
controversy whether an increased physical activity may
chronically influence hemostasis. In this regard, we con-
clude that gradually increased aerobic training regimens
may produce a modest but significant chronic activation
of primary hemostasis.
At variance with earlier studies, the innovative value of
this investigation is represented by the original study
design, involving a large subset of elite and professional
endurance athletes who were tested following a 12–24 h
resting period. Unfortunately, there is no definitive expla-
nation to justify the discrepant behavior between CADP
and CEPI in athletes. The activation of platelet adhesion/
aggregation can be induced by means of heavy exercise,
though warm-up exercise diminishes this effect in seden-
tary men [15]. Therefore, the continuous exercise, even of
low intensity and possibly not reported by the athletes,
may have contributed to the increased platelet responsive-
ness to CADP. Then, due to the inverse correlation
between hematocrit and closure time under all circum-
stances, the hematocrit value is an additional variable that
should be taken into consideration for the correct inter-
pretation of PFA-100 measurements [16]. Accordingly,
the different hematologic profile of competitive athletes
[17] may provide a further explanation for the discrep-
ancy observed between CADP and CEPI values in the ath-
letes population.
Conclusion
The influence of common variables influencing PFA-100
results such as acquired or congenital platelet disorders
and VWF levels has been accurately excluded in our study
populations. Therefore, the trend towards slightly lower
CADP values in athletes is suggestive for a moderate
chronic platelet activation and deserves further scrutiny,
highlighting that appropriate reference ranges for the PFA-
100 may be implemented when evaluating primary
hemostasis in physically active subjects.
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